Are Peptides Legal in Texas? (2026)

By the Peptide Bureau Research Team Regulation Reviewed by the Peptide Bureau Research Team on 28 September 2026

Not legal advice. This page summarises public statutes, board statements and enforcement records for Texas as of 28 September 2026, for general information. It is not a legal opinion. Laws change; check the linked sources or a licensed Texas attorney before relying on anything here. Compounds are discussed in a research context only.

Short answer. There is no Texas statute that bans buying or possessing research peptides as a category. Federal law does the regulating: selling an unapproved peptide for human use is a federal violation by the seller, and human growth hormone has its own federal statute. The Bureau found no peptide that Texas has scheduled or banned on its own. Texas also lists human growth hormone in its own controlled-substance law, on top of the federal rule. Verified against the sources listed at the bottom on 28 September 2026. Not legal advice.

Texas at a glance

State controlled-substances law: Texas Controlled Substances Act, Tex. Health & Safety Code ch. 481 (statutes.capitol.texas.gov)
Human growth hormone under state law: Listed as a controlled substance in state law (Tex. Health & Safety Code § 481.071(b) and (c)) (statutes.capitol.texas.gov)
Research peptides scheduled by the state: None found
Board of Pharmacy on compounded GLP-1s: No statement located
Medical board on peptide prescribing: No statement located
GLP-1 by telehealth: Yes. Tex. Occ. Code § 111.005 recognises a valid practitioner-patient relationship for telemedicine prescribing when the practitioner uses synchronous audiovisual interaction, store-and-forward technology with images or clinical records, or other audiovisual technology that meets the standard of care, with follow-up guidance. There is no statutory in-person examination requirement; a bare questionnaire does not satisfy the section. (statutes.capitol.texas.gov)
State-level enforcement, 2023 to 2026: 2 actions found
Last verified: 28 September 2026, confidence medium

The federal rules that apply in Texas, as everywhere

Federal law is the same in every state, and it is where almost all of the legal weight sits. Under the Federal Food, Drug, and Cosmetic Act a product intended to treat a condition or change how the body works is a drug, and an unapproved new drug cannot be introduced into interstate commerce. That rule binds the seller, not the buyer. The FDA's 2026 warning letters to research-peptide vendors say the same thing eleven times over: a "research use only" label does not help when the website, the bundled bacteriostatic water or a dosing calculator shows the product is meant for human use. The Bureau's enforcement tracker lists every letter, case and lawsuit with its source.

Three federal points matter for a reader in Texas:

Human growth hormone is the exception. 21 U.S.C. § 333(e) makes it a federal offence to distribute or possess somatropin for any use not approved by the Secretary of HHS. That statute covers HGH itself, not the secretagogues (sermorelin, ipamorelin, CJC-1295) that prompt the body's own release.
Compounding is a separate track. A licensed pharmacy may only compound from bulk substances on the FDA's 503A list. BPC-157, TB-500, MOTS-c, KPV, Semax and Epitalon were moved to Category 2 in September 2023, removed from it in April 2026, and recommended for the list by the FDA's advisory committee on 23 and 24 July 2026. No rule has followed as of September 2026, so they still cannot be legally compounded anywhere, including Texas. The PCAC vote page has every tally.
GLP-1 compounding is closing, not opening. The FDA has declared the semaglutide and tirzepatide shortages over, proposed in April 2026 to keep both off the 503B bulks list, and sent batches of letters to telehealth sellers in March and June 2026. Vials sold as "GLP-1 S" or "GLP-3 R" for research are unapproved new drugs in the FDA's view wherever the buyer lives.

What Texas law adds

Texas's controlled-substances law (Texas Controlled Substances Act, Tex. Health & Safety Code ch. 481) decides whether possessing a compound is a state offence. Peptides only become a state-law problem if they appear in those schedules or in a specific state ban. (statutes.capitol.texas.gov)

The Bureau found no research peptide (BPC-157, TB-500, ipamorelin, sermorelin, semaglutide, tirzepatide, retatrutide or the others covered on this site) on Texas's schedules or in a Texas-specific ban as of September 2026. That is the position in most states.

Human growth hormone

Section 481.071 says an anabolic steroid or human growth hormone listed in Schedule III may only be prescribed or dispensed by a practitioner for a valid medical purpose, and that bodybuilding, muscle enhancement or increasing bulk or strength in a healthy person is not a valid medical purpose. HGH is not in any penalty group (Penalty Group 3 covers anabolic steroids only); the current DSHS schedule PDF could not be opened, so the Schedule III listing is taken from the statute's own wording. (Tex. Health & Safety Code § 481.071(b) and (c)) (statutes.capitol.texas.gov)

Compounded semaglutide and tirzepatide

No Texas Board of Pharmacy statement specific to compounded GLP-1 drugs was located. Licensed Texas pharmacies follow the federal 503A and 503B rules, under which the shortage exception for semaglutide and tirzepatide has ended.

Clinics, medspas and prescribers

No Texas medical board guidance specific to peptide therapy was located. A Texas prescriber who administers BPC-157 or another unapproved peptide is exposed under the state's medical practice act and, since the FDA's 2026 letters, under federal law; the July 2026 advisory vote has not changed that yet.

Buying, possessing and using research peptides in Texas

Possessing an unscheduled research peptide such as BPC-157 is not a Texas Controlled Substances Act offence; possession offences attach to penalty-group substances and, under § 481.119(b), to substances the commissioner has scheduled but not penalty-grouped, a Class B misdemeanor, which is the provision that reaches HGH held without a prescription. (statutes.capitol.texas.gov)

Ordering from a vendor in another state. Almost every research-peptide order into Texas is interstate commerce, which is exactly what the FDCA governs. The risk sits with the vendor: the FDA's letters name the seller, and Eli Lilly said in August 2026 it had referred more than 200 sellers to the FDA, the DOJ, state attorneys general and licensing boards. Connecticut's attorney general has already used state consumer-protection law against a "research grade" GLP-1 seller (2025), which is the template other states can copy. The Bureau's vendor scorecard notes which vendors publish batch testing; none of the scored vendors appears in the tracker as of September 2026.

GLP-1 drugs by prescription. Yes. Tex. Occ. Code § 111.005 recognises a valid practitioner-patient relationship for telemedicine prescribing when the practitioner uses synchronous audiovisual interaction, store-and-forward technology with images or clinical records, or other audiovisual technology that meets the standard of care, with follow-up guidance. There is no statutory in-person examination requirement; a bare questionnaire does not satisfy the section. (statutes.capitol.texas.gov) The branded pens are the only fully approved route; compounded versions are now on the wrong side of the FDA's shortage rules.

Sports and employment testing are not a Texas law question. Growth hormone secretagogues and GHRH analogues are on the WADA Prohibited List everywhere; a standard workplace panel does not screen for peptides. The national legal guide covers both.

Not sure which of these you actually need?

Answer five questions about your goal, experience and budget and the Stack Builder shows you a matched research protocol on screen, with the compounds, cycle shape and vendor picks from the vendors we score.

Build your stack, 2 minutes

Enforcement in Texas

2026-08-12. Eli Lilly filed six federal lawsuits over retatrutide sales, five of them against Texas sellers: Astra Peptides, Legendary Peptides, Striker Pharmacy, Texas Peptides and Lone Star Peptide. Private litigation by the manufacturer, not a state action. (healio.com)
2026-08-24. The FDA's 24 August 2026 warning letters to online peptide sellers included TXP Innovations LLC, trading as Tex Peptides of Dallas, for marketing semaglutide, tirzepatide, retatrutide and other peptides as unapproved new drugs; and its 18 September 2026 letter went to Empower Pharmacy of Houston over compounded semaglutide and tirzepatide. Federal actions against Texas businesses. (peptidebureau.com)

A warning letter, lawsuit or board complaint is an allegation by the body that issued it, not a court finding, unless the entry says otherwise.

Editor's note. Texas is not among the signatories of the February 2025 multistate letter to the FDA. No Texas State Board of Pharmacy or Texas Medical Board statement on compounded GLP-1s or peptides, and no Texas attorney general action against GLP-1 or peptide sellers, was found within the search budget.

Frequently asked questions

Is BPC-157 legal in Texas?

Texas has not scheduled BPC-157, so possessing it is not a Texas offence. Federally it is an unapproved new drug: selling it for human use is a violation by the seller, and licensed pharmacies cannot compound it because it is not on the 503A bulks list, despite the advisory committee's July 2026 recommendation. Research vendors sell it under a research-use-only label, which the FDA's 2026 letters treat as no defence when the site shows human use.

Can I get semaglutide or tirzepatide by telehealth in Texas?

Yes. Tex. Occ. Code § 111.005 recognises a valid practitioner-patient relationship for telemedicine prescribing when the practitioner uses synchronous audiovisual interaction, store-and-forward technology with images or clinical records, or other audiovisual technology that meets the standard of care, with follow-up guidance. There is no statutory in-person examination requirement; a bare questionnaire does not satisfy the section. Compounded versions are no longer covered by the FDA's shortage exception, and the FDA has proposed keeping semaglutide and tirzepatide off the 503B bulks list, so expect availability of compounded product to keep shrinking.

Is HGH legal in Texas?

Only with a valid prescription. Texas lists human growth hormone as a controlled substance and federal law, 21 U.S.C. section 333(e), separately makes distribution or possession for a non-approved use a federal offence. Sermorelin, ipamorelin and CJC-1295 are not HGH and fall under the general unapproved-drug rules instead.

Sources

Every Texas fact above was checked against the linked source on 28 September 2026. If a statute or board position has changed, email [email protected] with the link and the page will be corrected and dated.